WebbShanghai RAAS Blood Products Co., Ltd. (SZSE:002252) agreed to acquire the remaining 10.23% stake in Tonrol Bio-Pharmaceutical Co., Limited from Huang Ruijie for CNY 550 million on November 21, 2016. Post acquisition, Shanghai RAAS Blood Products Co., Ltd. will hold 100% stake in Tonrol Bio-Pharmaceutical Co., Limited. Webb10 okt. 2024 · På denna sida hittar du historiska data för Shanghai RAAS Blood Products Co Ltd Class A stock (002252) liksom sista betalkursen, öppen, högsta, lägsta,, …
002252.CN Shanghai RAAS Blood Products Co. Ltd. Financial …
Webb7 apr. 2024 · Shanghai RAAS Blood Products Co., Ltd. se especializa en la investigación, desarrollo y fabricación de productos terapéuticos derivados del plasma. Los productos … WebbShanghai RAAS är huvudsakligen verksamt inom produktion och försäljning av blodprodukter, vaccin, diagnostiska reagenser och testutrustning och upptäcka teknik … glurakderbro school reloaded 7
Shanghai RAAS Blood Products - PitchBook Data
Webb13 apr. 2024 · As a result of this alliance, Shanghai RAAS will be the exclusive distributor of Grifols bioscience and diagnostic products in China. The operation fits in with the plans for expansion and access to plasma in which the company is immersed. The operation depends on approval by the competent regulatory authorities (China and US). Previous … WebbThis page offers an in-depth profile of Shanghai RAAS Blood Products Co Ltd Class A, including a general overview of the company's business and key management. Webb8 apr. 2024 · Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. About the company Rewards Price-To-Earnings ratio … glupker orthodontics reviews